Seegene Executive and Leadership Team

Jong-Yoon Chun, the Founder & Chief Executive Officer at Seegene, directs the company's overarching strategy and vision. Overseeing global operations, the Chief Executive Officer ensures alignment with corporate objectives in developing multiplex molecular technologies and clinical diagnostics. This leadership role involves expanding market share through digital campaigns. By optimizing the sales funnel, Jong-Yoon Chun directly impacts the company's growth. Ultimately, Chun secures long-term financial stability. The Founder & Chief Executive Officer drives Seegene's mission to provide advanced M-MoDx solutions, leveraging extensive experience in the biotechnology sector to foster innovation and maintain a competitive edge in the global diagnostics market. This executive's strategic guidance is paramount to Seegene's continued success and its commitment to improving patient outcomes through precise molecular testing.

James Yantzi, the President at Seegene, spearheads market expansion and strategic business development initiatives. Leading global sales and marketing efforts, the President drives the adoption of Seegene's multiplex molecular diagnostics across diverse international markets. This position involves forging key alliances and cultivating relationships with healthcare providers and distribution partners worldwide. By identifying emerging market opportunities, James Yantzi directly enhances Seegene's global footprint. Ultimately, Yantzi strengthens Seegene's market presence. The President's focus on commercial strategy ensures that Seegene's innovative M-MoDx solutions reach a wider audience, contributing significantly to the company's revenue growth and its mission to improve global health outcomes through advanced molecular testing. James Yantzi's leadership is instrumental in translating technological achievements into widespread clinical application.

Min-Cheol Lee, the Chief Technology Officer at Seegene, architects the company's technological roadmap and innovation pipeline. Overseeing research and development, the Chief Technology Officer drives advancements in multiplex molecular technologies and M-MoDx platforms. This role involves guiding scientific teams in exploring novel diagnostic methodologies and ensuring the scalability and robustness of Seegene's technological infrastructure. By fostering a culture of continuous improvement, Min-Cheol Lee directly accelerates the pace of innovation. Ultimately, Lee ensures Seegene remains at the forefront of molecular diagnostics. The Chief Technology Officer's expertise is crucial for maintaining Seegene's competitive advantage, focusing on developing next-generation diagnostic tools that address evolving healthcare needs and expanding the company's intellectual property portfolio. Min-Cheol Lee's technical leadership is fundamental to Seegene's mission.

Daehoon Lee, the Managing Director at Seegene, oversees critical operational functions and resource allocation. Managing Director ensures the efficient execution of Seegene's business strategies, focusing on the development and deployment of multiplex molecular diagnostics. This position involves coordinating cross-functional teams to achieve production targets and maintain high standards of quality control. By streamlining internal processes, Daehoon Lee directly contributes to the company's operational efficiency. Ultimately, Lee enhances Seegene's capacity to deliver innovative M-MoDx solutions. The Managing Director's responsibilities extend to managing key partnerships and ensuring the smooth integration of new technologies into existing workflows, thereby supporting Seegene's expansion into new markets and reinforcing its position as a leader in molecular diagnostics. Daehoon Lee's operational acumen is vital for translating technological advancements into tangible market successes.